Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: Can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?

Journal of Thoracic Oncology

Volumn 1, Issue 8, 2006, Pages 816-824

  Sundstrøm, Stein ^a,b   Bremnes, Roy M ^c,d   Brunsvig, Paal ^e   Aasebø, Ulf ^c,d   Kaasa, Stein ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Palliative radiotherapy; Prognostic factors; Stage III non small

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LONG TERM CARE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVERALL SURVIVAL; PATIENT ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; SHORT COURSE THERAPY; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; DISEASE FREE SURVIVAL; LUNG TUMOR; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; RADIATION DOSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 34248354440     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200610000-00010     Document Type: Article

References (33)

1. Roila F, Cortesi E. Quality of life as a primary end point in oncology. Ann Oncol 2001;12(Suppl):3S-6S.
2. Kaasa S, Loge JH. Quality-of-life assessment in palliative care. Lancet Oncol 2002;3:175-182.
3. Coates A, Porzolt F, Osoba D. Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997;7:1025-1030.
4. Coates AS, Hürny C, Peterson HF, et al. Quality-of-life-scores predict outcome in metastatic but not early breast cancer. J Clin Onc 2000;18:3768-3774.
5. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiother Oncol 1989;15:235-242.
6. Ganz PA, Lee JJ, Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 1991;15:3131-3135.
7. Langendijk JA, Aaronson NK, ten Velde GPM, et al. Pretreatment quality of life in inoperable non-small cell lung cancer patients referred for primary radiotherapy. Acta Onc 2000;39:949-958.
8. Langendijk H, Aaronson NK, de Jong J MA, et al. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000;55:19-25.
9. Eton DT, Fairclough DL, Cella D, et al. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: Results from Eastern Cooperative Oncology Group Study 5592. J Clin Onc 2003;21:1536-1543.
10. M. R. C. Lung Cancer Working Party, Bleehan NM, Girling DJ, Fayers PM. Inoperable non-small cell lung cancer (NSCLC): A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 1991;63:265-270.
11. M. R. C. Lung Cancer Working Party, Bleehan NM, Girling DJ, Machin D. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992;65:934-941.
12. Sundstrøm S, Bremnes R, Aasebø U, et al. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma (NSCLC) is comparable to standard fractionation for symptom control and survival: A national phase III trial. J Clin Oncol 2004;22:801-810.
13. Macbeth F, Toy E, Coles B, et al. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 2002;1:CD002143.
14. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-233S.
15. Kirk J, Gray WM, Watson ER. Cumulative radiation effect. Part I. Fractionated treatment regimes. Clin Radiol 1971;22:145-155.
16. Aaronson NK, Ahmedzai S, Bergmann B, et al. The European Organization for Research and Treatment of Cancer QLQ-C-30: A quality-oflife instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
17. Bergmann B, Aaronson NK, Ahmedzai S, et al. The EORTC QLQLC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 1994;30A:635-642.
18. Fayers PM, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 Scoring Manual. Brussels, Belgium: EORTC Quality of Life Study Group, 1995.
19. Kaplan EI, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assos 1958;53:457-481.
20. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-202.
21. Macbeth FR, Bolger JJ, Hopwood P, et al. Randomised trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) 1996;8:167-175.
22. Reinfuss M, Glinski B, Kowalska T, et al. Radiothérapie du cancer bronchique non à petite cellules de stade III, inopérable, asymptomatique. Résultats définitifs d/un essai prospectif randomisé (240 patients). Cancer Radiotherapie 1999;3:475-479.
23. Kramer GWPM, Stofferinus LW, Noordijk EM, et al. Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small cell lung cancer. J Clin Onc 2006;23:2962-2970.
24. Simpson JR, Francis ME, Perez-Tamayo R, et al. Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 1985;11:751-758.
25. Abratt RP, Shepard LJ, Mameena Salton, DG. Palliative radiation for stage 3 non-small cell lung cancer - a prospective study of two moderately high dose regimens. Lung Cancer 1995;13:137-143.
26. Teo P, Tai H, Choy D, et al. A randomised study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1988;14:867-871.
27. Bezjak A, Dixon P, Brundage M, et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC. 15). Int J Radiat Oncol Biol Phys 2002;54:719-728.
28. Senkus-Konefka E, Dziadzuszko R, Bednaruk-Mlynski E, et al. A prospective, randomised study to compare two palliative radiotherapy schedules for non-small cell lung cancer (NSCLC). Br J Cancer 2006;92:1038-1045.
29. Jeremic B, Shibamoto Y. Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy. Lung Cancer 1995;13:21-30.
30. Ando M, Ando Y, Hasegawa Y, et al. Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer 2001;85:1634-1639.
31. Firat S, Byhardt RW, Gore E. Comorbidity and Karnofsky performance score are independent prognostic factors in stage III non-small cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Int J Radiat Oncol Biol Phys 2002;54:357-364.
32. Montazeri A, Milroy R, Hole D, et al. Quality of life in lung cancer patients, as an important prognostic factor. Lung Cancer 2001:233-240.
33. Herndon JE, Fleishman S, Kornblith AB, et al. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999;85:333-340.